P-109 Broaden the therapeutic opportunities for colorectal cancer: ALK inhibition benefits consensus molecular subtype 1 patients
Mazzeschi, M., Sgarzi, M., Romaniello, D., Ambrosi, F., Morselli, A., Girone, C., Pagano, F., Rihawi, K., D'Uva, G., Ferracin, M., Fiorentino, M., Ardizzoni, A., Győrffy, B., Palmer, R., Li, N., Lengner, C., Mossé, Y., Lauriola, M.
Published in Annals of oncology (01.06.2023)
Published in Annals of oncology (01.06.2023)
Get full text
Journal Article
A revision of the Combined Drought Indicator (CDI) used in the European Drought Observatory (EDO)
Cammalleri, Carmelo, Arias-Muñoz, Carolina, Barbosa, Paulo, de Jager, Alfred, Magni, Diego, Masante, Dario, Mazzeschi, Marco, McCormick, Niall, Naumann, Gustavo, Spinoni, Jonathan, Vogt, Jürgen
Published in Natural hazards and earth system sciences (02.02.2021)
Published in Natural hazards and earth system sciences (02.02.2021)
Get full text
Journal Article
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
Mazzeschi, Martina, Sgarzi, Michela, Romaniello, Donatella, Gelfo, Valerio, Cavallo, Carola, Ambrosi, Francesca, Morselli, Alessandra, Miano, Carmen, Laprovitera, Noemi, Girone, Cinzia, Ferracin, Manuela, Santi, Spartaco, Rihawi, Karim, Ardizzoni, Andrea, Fiorentino, Michelangelo, D'Uva, Gabriele, Győrffy, Balázs, Palmer, Ruth, Lauriola, Mattia
Published in Journal of experimental & clinical cancer research (29.03.2022)
Published in Journal of experimental & clinical cancer research (29.03.2022)
Get full text
Journal Article